Oct 7 (Reuters)-
AFC-HD Ams Life Science Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Aug 31, 2016 Aug 31, 2015 Aug 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 14.63 14.42 15.00 7.40
(+1.5 pct) (+5.0 pct) (+2.5 pct) (-0.2 pct)
Operating 890 mln 951 mln 1.05 500 mln
(-6.3 pct) (+68.5 pct) (+17.9 pct) (-6.7 pct)
Recurring 812 mln 892 mln 1.00 470 mln
(-8.9 pct) (+75.7 pct) (+23.1 pct) (-5.9 pct)
Net
Net 489 mln 605 mln 600 mln 300 mln
(-19.1 pct) (+114.0 pct) (+22.5 pct) (-11.6 pct)
EPS 40.47 yen 50.64 yen 49.55 yen 24.77 yen
EPS Diluted 40.34 yen 50.00 yen
Ann Div 15.00 yen 15.00 yen 10.00 yen
-Q2 Div 5.00 yen 5.00 yen 5.00 yen
-Q4 Div 10.00 yen 10.00 yen 5.00 yen
NOTE - AFC-HD Ams Life Science Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T
((Tokyo Headline News Desk +813 6441 1812))